Margaret T. Lee

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 496 citations · Full text

Pediatric Hematology, Hematology, Neurological Monitoring +10

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

Margaret T. Lee, Sergio Piomelli, Suzanne Granger et al. · Blood · 2006 · 307 citations · Full text

Consensus-Derived Practice Standards Plan for Complicated Kaposiform Hemangioendothelioma

Beth A. Drolet, Cameron C. Trenor, Leonardo R. Brandão et al. · The Journal of Pediatrics · 2013 · 276 citations

Hematology, Vascular Malformation, Vascular Surgery +4

Adapting Washington Circle performance measures for public sector substance abuse treatment systems

Deborah W. Garnick, Margaret T. Lee, Constance M. Horgan et al. · Journal of Substance Abuse Treatment · 2008 · 138 citations · Full text

Substance Abuse, Public Policy, Substance Use +9

Establishing the feasibility of performance measures for alcohol and other drugs

Deborah W. Garnick, Margaret T. Lee, Mady Chalk et al. · Journal of Substance Abuse Treatment · 2002 · 129 citations · Full text

Substance Abuse, Substance Use, Performance Studies +10